These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38804639)

  • 1. Evaluation of the QMAC-dRAST System Version 2.5 for Rapid Antimicrobial Susceptibility Testing of Gram-Negative Bacteria From Positive Blood Culture Broth and Subcultured Colony Isolates.
    Kim TY; Kang M; Shim HJ; Kang OK; Huh HJ; Lee NY
    J Clin Lab Anal; 2024 May; 38(9):e25043. PubMed ID: 38804639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance evaluation of the QMAC-dRAST for staphylococci and enterococci isolated from blood culture: a comparative study of performance with the VITEK-2 system.
    Huh HJ; Song DJ; Shim HJ; Kwon WK; Park MS; Ryu MR; Cho EH; Oh J; Yoo IY; Lee NY
    J Antimicrob Chemother; 2018 May; 73(5):1267-1271. PubMed ID: 29415214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QMAC-dRAST for the direct testing of antibiotic susceptibility for Enterobacterales in positive blood-culture broth: a comparison of the performances with the MicroScan system and direct disc diffusion testing methods.
    Gallois E; Fihman V; Danjean M; Gomart C; Kimseng H; Le Guen R; Royer G; Woerther PL
    J Antimicrob Chemother; 2023 Mar; 78(3):684-691. PubMed ID: 36611274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of version 2.5 of QMAC-dRAST for rapid antimicrobial susceptibility testing with reduced sample-to-answer turnaround time and an integrated expert system.
    Grohs P; Picard S; Mainardi JL; Podglajen I
    Infect Dis Now; 2021 Aug; 51(5):470-476. PubMed ID: 34366083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the QMAC-dRAST V2.0 system for rapid antibiotic susceptibility testing of Gram-negative blood culture isolates.
    Grohs P; Rondinaud E; Fourar M; Rouis K; Mainardi JL; Podglajen I
    J Microbiol Methods; 2020 May; 172():105902. PubMed ID: 32205178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance Evaluation of the Quantamatrix QMAC-dRAST System for Rapid Antibiotic Susceptibility Testing Directly from Blood Cultures.
    Rosselin M; Prod'hom G; Greub G; Croxatto A
    Microorganisms; 2022 Jun; 10(6):. PubMed ID: 35744730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of dRAST on Prospective Clinical Blood Culture Samples in a Simulated Clinical Setting and on Multidrug-Resistant Bacteria.
    Wong AYW; Johnsson ATA; Özenci V
    Microbiol Spectr; 2022 Apr; 10(2):e0210721. PubMed ID: 35234503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct, rapid antimicrobial susceptibility test from positive blood cultures based on microscopic imaging analysis.
    Choi J; Jeong HY; Lee GY; Han S; Han S; Jin B; Lim T; Kim S; Kim DY; Kim HC; Kim EC; Song SH; Kim TS; Kwon S
    Sci Rep; 2017 Apr; 7(1):1148. PubMed ID: 28442767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno™ and VITEK® 2 systems with the broth microdilution method.
    De Angelis G; Posteraro B; Menchinelli G; Liotti FM; Spanu T; Sanguinetti M
    J Antimicrob Chemother; 2019 Jan; 74(Suppl 1):i24-i31. PubMed ID: 30690539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of ASTA SepsiPrep kit in direct bacterial identification and antimicrobial susceptibility test using MicroIDSys Elite and VITEK-2 system.
    Yoo IY; Han J; Ha SI; Cha YJ; Pil SD; Park YJ
    J Clin Lab Anal; 2021 Jun; 35(6):e23744. PubMed ID: 33939213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Quantamatrix dRAST
    Morecchiato F; Coppi M; Chilleri C; Antonelli A; Giani T; Rossolini GM
    Diagn Microbiol Infect Dis; 2024 Jul; 110(1):116436. PubMed ID: 39003931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of EUCAST rapid antimicrobial susceptibility testing (RAST) directly from blood culture bottles.
    Soo YT; Waled SNMB; Ng S; Peh YH; Chew KL
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):993-998. PubMed ID: 31955354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of a System for Rapid Phenotypic Antimicrobial Susceptibility Testing of Gram-Negative Bacteria Directly from Positive Blood Culture Bottles.
    Göransson J; Sundqvist M; Ghaderi E; Lisby JG; Molin Y; Eriksson E; Carlsson S; Cederlöf A; Ellis L; Melin J
    J Clin Microbiol; 2023 Mar; 61(3):e0152522. PubMed ID: 36852983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of a rapid antimicrobial susceptibility test (QMAC-dRAST) for selecting optimal targeted antibiotics in positive blood culture.
    Kim JH; Kim TS; Jung HG; Kang CK; Jun KI; Han S; Kim DY; Kwon S; Song KH; Choe PG; Bang JH; Kim ES; Park SW; Kim HB; Kim NJ; Park WB; Oh MD
    J Antimicrob Chemother; 2019 Aug; 74(8):2255-2260. PubMed ID: 31038158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance and potential clinical impact of Alfred60
    Van den Poel B; Meersseman P; Debaveye Y; Klak A; Verhaegen J; Desmet S
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):53-63. PubMed ID: 31624985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Alfred AST® system for rapid antimicrobial susceptibility testing directly from positive blood cultures.
    Sánchez-Carrillo C; Pescador P; Ricote R; Fuentes J; Losada C; Candela A; Cercenado E
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1665-1670. PubMed ID: 31119576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.
    Pancholi P; Carroll KC; Buchan BW; Chan RC; Dhiman N; Ford B; Granato PA; Harrington AT; Hernandez DR; Humphries RM; Jindra MR; Ledeboer NA; Miller SA; Mochon AB; Morgan MA; Patel R; Schreckenberger PC; Stamper PD; Simner PJ; Tucci NE; Zimmerman C; Wolk DM
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints.
    Bobenchik AM; Deak E; Hindler JA; Charlton CL; Humphries RM
    J Clin Microbiol; 2015 Mar; 53(3):816-23. PubMed ID: 25540403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of novel rapid diagnostic of blood culture identification and antimicrobial susceptibility testing by Accelerate Pheno system and BioFire FilmArray Blood Culture Identification and BioFire FilmArray Blood Culture Identification 2 panels.
    Sze DTT; Lau CCY; Chan TM; Ma ESK; Tang BSF
    BMC Microbiol; 2021 Dec; 21(1):350. PubMed ID: 34922463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of Vitek®2 and broth microdilution method for colistin susceptibility testing of Gram-negative isolates from intensive care unit in a tertiary care hospital.
    Ananda T; Vandana KE; Mukhopadhyay C
    Indian J Med Microbiol; 2024; 48():100559. PubMed ID: 38447856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.